These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25269558)

  • 21. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
    Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
    Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
    Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
    Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
    Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
    Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax.
    Park SJ; Park SH; Kim JO; Kim JH; Park SJ; Hwang JJ; Jin DH; Jeong SY; Lee SJ; Kim JC; Kim I; Cho DH
    Biochem Biophys Res Commun; 2012 Nov; 428(1):185-90. PubMed ID: 23068102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NO TRAIL to YES TRAIL in cancer therapy (review).
    Lee JY; Huerta-Yepez S; Vega M; Baritaki S; Spandidos DA; Bonavida B
    Int J Oncol; 2007 Oct; 31(4):685-91. PubMed ID: 17786298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long and winding road to cancer treatment: the TRAIL system.
    Palacios C; Yerbes R; Sanchez-Perez T; Martin-Perez R; Cano-Gonzalez A; Lopez-Rivas A
    Curr Pharm Des; 2014; 20(17):2819-33. PubMed ID: 23944369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis.
    Sanlioglu AD; Koksal IT; Karacay B; Baykara M; Luleci G; Sanlioglu S
    Cancer Gene Ther; 2006 Jan; 13(1):21-31. PubMed ID: 16052230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
    Braeuer SJ; Büneker C; Mohr A; Zwacka RM
    Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of sensitivity to TRAIL by the PTEN tumor suppressor.
    Whang YE; Yuan XJ; Liu Y; Majumder S; Lewis TD
    Vitam Horm; 2004; 67():409-26. PubMed ID: 15110188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAILing death in cancer.
    Mellier G; Huang S; Shenoy K; Pervaiz S
    Mol Aspects Med; 2010 Feb; 31(1):93-112. PubMed ID: 19995571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells.
    Deng LL; Shao YX; Lv HF; Deng HB; Lv FZ
    Neoplasma; 2012; 59(1):18-29. PubMed ID: 22017589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
    Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
    J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and tolerability of TRAIL receptor agonists in cancer treatment.
    Fulda S
    Eur J Clin Pharmacol; 2015 May; 71(5):525-7. PubMed ID: 25704217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells.
    Florean C; Schnekenburger M; Lee JY; Kim KR; Mazumder A; Song S; Kim JM; Grandjenette C; Kim JG; Yoon AY; Dicato M; Kim KW; Christov C; Han BW; Proksch P; Diederich M
    Oncotarget; 2016 Apr; 7(17):24027-49. PubMed ID: 27006469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.
    Cretney E; Takeda K; Smyth MJ
    Int J Biochem Cell Biol; 2007; 39(2):280-6. PubMed ID: 17097329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin.
    Hartung F; Pardo LA
    Eur Biophys J; 2016 Oct; 45(7):709-719. PubMed ID: 27350552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.